nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—CYP2C19—Vismodegib—skin cancer	0.219	0.28	CbGbCtD
Chlorpropamide—CYP2C9—Vismodegib—skin cancer	0.182	0.232	CbGbCtD
Chlorpropamide—ABCB1—Vismodegib—skin cancer	0.177	0.226	CbGbCtD
Chlorpropamide—ABCB1—Dactinomycin—skin cancer	0.0929	0.119	CbGbCtD
Chlorpropamide—CYP2C9—Fluorouracil—skin cancer	0.0647	0.0826	CbGbCtD
Chlorpropamide—ABCB1—Docetaxel—skin cancer	0.0479	0.0612	CbGbCtD
Chlorpropamide—ABCC8—penis—skin cancer	0.0079	0.307	CbGeAlD
Chlorpropamide—Hyponatraemia—Vismodegib—skin cancer	0.00764	0.04	CcSEcCtD
Chlorpropamide—Eruption—Dactinomycin—skin cancer	0.00595	0.0311	CcSEcCtD
Chlorpropamide—Digestion impaired—Temozolomide—skin cancer	0.00495	0.0259	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Imiquimod—skin cancer	0.00425	0.0222	CcSEcCtD
Chlorpropamide—Eosinophilia—Vemurafenib—skin cancer	0.00402	0.0211	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Vemurafenib—skin cancer	0.00371	0.0194	CcSEcCtD
Chlorpropamide—Eruption—Docetaxel—skin cancer	0.00358	0.0187	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Dactinomycin—skin cancer	0.00343	0.018	CcSEcCtD
Chlorpropamide—Dyspepsia—Vismodegib—skin cancer	0.00329	0.0172	CcSEcCtD
Chlorpropamide—Pancytopenia—Imiquimod—skin cancer	0.00329	0.0172	CcSEcCtD
Chlorpropamide—Decreased appetite—Vismodegib—skin cancer	0.00325	0.017	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Vismodegib—skin cancer	0.00323	0.0169	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Imiquimod—skin cancer	0.00316	0.0166	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Temozolomide—skin cancer	0.00311	0.0163	CcSEcCtD
Chlorpropamide—Erythema multiforme—Vemurafenib—skin cancer	0.00307	0.0161	CcSEcCtD
Chlorpropamide—Pruritus—Vismodegib—skin cancer	0.00264	0.0139	CcSEcCtD
Chlorpropamide—Erythema multiforme—Imiquimod—skin cancer	0.00262	0.0137	CcSEcCtD
Chlorpropamide—Diarrhoea—Vismodegib—skin cancer	0.00256	0.0134	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Temozolomide—skin cancer	0.00254	0.0133	CcSEcCtD
Chlorpropamide—Vomiting—Vismodegib—skin cancer	0.00238	0.0124	CcSEcCtD
Chlorpropamide—Drug interaction—Docetaxel—skin cancer	0.00237	0.0124	CcSEcCtD
Chlorpropamide—Rash—Vismodegib—skin cancer	0.00236	0.0123	CcSEcCtD
Chlorpropamide—Pancytopenia—Bleomycin—skin cancer	0.00234	0.0122	CcSEcCtD
Chlorpropamide—Nausea—Vismodegib—skin cancer	0.00222	0.0116	CcSEcCtD
Chlorpropamide—Pancytopenia—Dactinomycin—skin cancer	0.00218	0.0114	CcSEcCtD
Chlorpropamide—Fluid retention—Docetaxel—skin cancer	0.00209	0.0109	CcSEcCtD
Chlorpropamide—Decreased appetite—Vemurafenib—skin cancer	0.00201	0.0105	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00199	0.0104	CcSEcCtD
Chlorpropamide—Pancytopenia—Temozolomide—skin cancer	0.00197	0.0103	CcSEcCtD
Chlorpropamide—Agranulocytosis—Dactinomycin—skin cancer	0.00191	0.01	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Temozolomide—skin cancer	0.00189	0.00992	CcSEcCtD
Chlorpropamide—Eosinophilia—Fluorouracil—skin cancer	0.00189	0.00992	CcSEcCtD
Chlorpropamide—Anorexia—Imiquimod—skin cancer	0.00188	0.00983	CcSEcCtD
Chlorpropamide—Pancytopenia—Fluorouracil—skin cancer	0.00182	0.00951	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Fluorouracil—skin cancer	0.00175	0.00914	CcSEcCtD
Chlorpropamide—Erythema multiforme—Dactinomycin—skin cancer	0.00174	0.0091	CcSEcCtD
Chlorpropamide—Dyspepsia—Imiquimod—skin cancer	0.00173	0.00908	CcSEcCtD
Chlorpropamide—Decreased appetite—Imiquimod—skin cancer	0.00171	0.00897	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Imiquimod—skin cancer	0.0017	0.00891	CcSEcCtD
Chlorpropamide—Pruritus—Vemurafenib—skin cancer	0.00163	0.00856	CcSEcCtD
Chlorpropamide—Hyponatraemia—Docetaxel—skin cancer	0.0016	0.0084	CcSEcCtD
Chlorpropamide—Agranulocytosis—Fluorouracil—skin cancer	0.00159	0.00833	CcSEcCtD
Chlorpropamide—Diarrhoea—Vemurafenib—skin cancer	0.00158	0.00828	CcSEcCtD
Chlorpropamide—Erythema multiforme—Temozolomide—skin cancer	0.00157	0.00823	CcSEcCtD
Chlorpropamide—Urticaria—Imiquimod—skin cancer	0.00156	0.0082	CcSEcCtD
Chlorpropamide—Leukopenia—Bleomycin—skin cancer	0.00153	0.00804	CcSEcCtD
Chlorpropamide—Dizziness—Vemurafenib—skin cancer	0.00153	0.008	CcSEcCtD
Chlorpropamide—Vomiting—Vemurafenib—skin cancer	0.00147	0.00769	CcSEcCtD
Chlorpropamide—Rash—Vemurafenib—skin cancer	0.00146	0.00763	CcSEcCtD
Chlorpropamide—Headache—Vemurafenib—skin cancer	0.00145	0.00758	CcSEcCtD
Chlorpropamide—Leukopenia—Dactinomycin—skin cancer	0.00143	0.0075	CcSEcCtD
Chlorpropamide—Pruritus—Imiquimod—skin cancer	0.00139	0.0073	CcSEcCtD
Chlorpropamide—Nausea—Vemurafenib—skin cancer	0.00137	0.00719	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Bleomycin—skin cancer	0.00137	0.00718	CcSEcCtD
Chlorpropamide—Diarrhoea—Imiquimod—skin cancer	0.00135	0.00706	CcSEcCtD
Chlorpropamide—Anorexia—Bleomycin—skin cancer	0.00133	0.00699	CcSEcCtD
Chlorpropamide—SLC15A1—epithelium—skin cancer	0.00133	0.0516	CbGeAlD
Chlorpropamide—Pancytopenia—Docetaxel—skin cancer	0.00131	0.00687	CcSEcCtD
Chlorpropamide—Dizziness—Imiquimod—skin cancer	0.0013	0.00682	CcSEcCtD
Chlorpropamide—Leukopenia—Temozolomide—skin cancer	0.00129	0.00678	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Dactinomycin—skin cancer	0.00128	0.00669	CcSEcCtD
Chlorpropamide—PTGS1—endothelium—skin cancer	0.00126	0.0491	CbGeAlD
Chlorpropamide—Vomiting—Imiquimod—skin cancer	0.00125	0.00656	CcSEcCtD
Chlorpropamide—Anorexia—Dactinomycin—skin cancer	0.00124	0.00652	CcSEcCtD
Chlorpropamide—Rash—Imiquimod—skin cancer	0.00124	0.0065	CcSEcCtD
Chlorpropamide—Headache—Imiquimod—skin cancer	0.00123	0.00646	CcSEcCtD
Chlorpropamide—Decreased appetite—Bleomycin—skin cancer	0.00122	0.00637	CcSEcCtD
Chlorpropamide—Leukopenia—Fluorouracil—skin cancer	0.00119	0.00625	CcSEcCtD
Chlorpropamide—Nausea—Imiquimod—skin cancer	0.00117	0.00613	CcSEcCtD
Chlorpropamide—PTGS1—blood vessel—skin cancer	0.00116	0.0452	CbGeAlD
Chlorpropamide—KCNJ11—lymphoid tissue—skin cancer	0.00116	0.0451	CbGeAlD
Chlorpropamide—Thrombocytopenia—Temozolomide—skin cancer	0.00116	0.00605	CcSEcCtD
Chlorpropamide—SLC15A1—mammalian vulva—skin cancer	0.00115	0.0448	CbGeAlD
Chlorpropamide—Agranulocytosis—Docetaxel—skin cancer	0.00115	0.00602	CcSEcCtD
Chlorpropamide—Decreased appetite—Dactinomycin—skin cancer	0.00113	0.00594	CcSEcCtD
Chlorpropamide—Anorexia—Temozolomide—skin cancer	0.00113	0.00589	CcSEcCtD
Chlorpropamide—KCNJ11—female reproductive system—skin cancer	0.00112	0.0435	CbGeAlD
Chlorpropamide—Urticaria—Bleomycin—skin cancer	0.00111	0.00582	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Fluorouracil—skin cancer	0.00106	0.00558	CcSEcCtD
Chlorpropamide—Erythema multiforme—Docetaxel—skin cancer	0.00104	0.00547	CcSEcCtD
Chlorpropamide—Dyspepsia—Temozolomide—skin cancer	0.00104	0.00544	CcSEcCtD
Chlorpropamide—Anorexia—Fluorouracil—skin cancer	0.00104	0.00543	CcSEcCtD
Chlorpropamide—Decreased appetite—Temozolomide—skin cancer	0.00103	0.00537	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Temozolomide—skin cancer	0.00102	0.00534	CcSEcCtD
Chlorpropamide—Pruritus—Bleomycin—skin cancer	0.00099	0.00519	CcSEcCtD
Chlorpropamide—Dyspepsia—Fluorouracil—skin cancer	0.000957	0.00501	CcSEcCtD
Chlorpropamide—Decreased appetite—Fluorouracil—skin cancer	0.000945	0.00495	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000939	0.00492	CcSEcCtD
Chlorpropamide—Urticaria—Temozolomide—skin cancer	0.000938	0.00491	CcSEcCtD
Chlorpropamide—KCNJ11—head—skin cancer	0.000935	0.0364	CbGeAlD
Chlorpropamide—Diarrhoea—Dactinomycin—skin cancer	0.000893	0.00468	CcSEcCtD
Chlorpropamide—Vomiting—Bleomycin—skin cancer	0.00089	0.00466	CcSEcCtD
Chlorpropamide—Rash—Bleomycin—skin cancer	0.000882	0.00462	CcSEcCtD
Chlorpropamide—Urticaria—Fluorouracil—skin cancer	0.000864	0.00453	CcSEcCtD
Chlorpropamide—Leukopenia—Docetaxel—skin cancer	0.000861	0.00451	CcSEcCtD
Chlorpropamide—ABCC8—head—skin cancer	0.000861	0.0335	CbGeAlD
Chlorpropamide—PTGS1—nipple—skin cancer	0.000841	0.0327	CbGeAlD
Chlorpropamide—Pruritus—Temozolomide—skin cancer	0.000835	0.00437	CcSEcCtD
Chlorpropamide—Nausea—Bleomycin—skin cancer	0.000831	0.00435	CcSEcCtD
Chlorpropamide—Vomiting—Dactinomycin—skin cancer	0.00083	0.00435	CcSEcCtD
Chlorpropamide—Rash—Dactinomycin—skin cancer	0.000823	0.00431	CcSEcCtD
Chlorpropamide—Diarrhoea—Temozolomide—skin cancer	0.000808	0.00423	CcSEcCtD
Chlorpropamide—Dizziness—Temozolomide—skin cancer	0.00078	0.00409	CcSEcCtD
Chlorpropamide—Nausea—Dactinomycin—skin cancer	0.000775	0.00406	CcSEcCtD
Chlorpropamide—Pruritus—Fluorouracil—skin cancer	0.000769	0.00403	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Docetaxel—skin cancer	0.000768	0.00403	CcSEcCtD
Chlorpropamide—Vomiting—Temozolomide—skin cancer	0.00075	0.00393	CcSEcCtD
Chlorpropamide—Anorexia—Docetaxel—skin cancer	0.000748	0.00392	CcSEcCtD
Chlorpropamide—Rash—Temozolomide—skin cancer	0.000744	0.0039	CcSEcCtD
Chlorpropamide—Diarrhoea—Fluorouracil—skin cancer	0.000744	0.0039	CcSEcCtD
Chlorpropamide—Headache—Temozolomide—skin cancer	0.000739	0.00387	CcSEcCtD
Chlorpropamide—Dizziness—Fluorouracil—skin cancer	0.000719	0.00377	CcSEcCtD
Chlorpropamide—Nausea—Temozolomide—skin cancer	0.000701	0.00367	CcSEcCtD
Chlorpropamide—Vomiting—Fluorouracil—skin cancer	0.000691	0.00362	CcSEcCtD
Chlorpropamide—Dyspepsia—Docetaxel—skin cancer	0.000691	0.00362	CcSEcCtD
Chlorpropamide—ABCB1—blood vessel—skin cancer	0.000688	0.0268	CbGeAlD
Chlorpropamide—Rash—Fluorouracil—skin cancer	0.000686	0.00359	CcSEcCtD
Chlorpropamide—Decreased appetite—Docetaxel—skin cancer	0.000682	0.00357	CcSEcCtD
Chlorpropamide—Headache—Fluorouracil—skin cancer	0.000681	0.00357	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Docetaxel—skin cancer	0.000678	0.00355	CcSEcCtD
Chlorpropamide—KCNJ11—lymph node—skin cancer	0.000654	0.0255	CbGeAlD
Chlorpropamide—Nausea—Fluorouracil—skin cancer	0.000646	0.00338	CcSEcCtD
Chlorpropamide—SLC15A2—female reproductive system—skin cancer	0.000616	0.024	CbGeAlD
Chlorpropamide—PTGS1—connective tissue—skin cancer	0.000596	0.0232	CbGeAlD
Chlorpropamide—PTGS1—epithelium—skin cancer	0.000566	0.022	CbGeAlD
Chlorpropamide—Pruritus—Docetaxel—skin cancer	0.000555	0.00291	CcSEcCtD
Chlorpropamide—PTGS1—skin of body—skin cancer	0.000538	0.0209	CbGeAlD
Chlorpropamide—Diarrhoea—Docetaxel—skin cancer	0.000537	0.00281	CcSEcCtD
Chlorpropamide—Dizziness—Docetaxel—skin cancer	0.000519	0.00272	CcSEcCtD
Chlorpropamide—SLC15A2—head—skin cancer	0.000514	0.02	CbGeAlD
Chlorpropamide—Vomiting—Docetaxel—skin cancer	0.000499	0.00261	CcSEcCtD
Chlorpropamide—Rash—Docetaxel—skin cancer	0.000495	0.00259	CcSEcCtD
Chlorpropamide—Headache—Docetaxel—skin cancer	0.000492	0.00258	CcSEcCtD
Chlorpropamide—PTGS1—mammalian vulva—skin cancer	0.000491	0.0191	CbGeAlD
Chlorpropamide—Nausea—Docetaxel—skin cancer	0.000466	0.00244	CcSEcCtD
Chlorpropamide—CYP2C9—female reproductive system—skin cancer	0.000461	0.0179	CbGeAlD
Chlorpropamide—PTGS1—female reproductive system—skin cancer	0.00042	0.0164	CbGeAlD
Chlorpropamide—SLC15A2—lymph node—skin cancer	0.00036	0.014	CbGeAlD
Chlorpropamide—PTGS1—head—skin cancer	0.000351	0.0137	CbGeAlD
Chlorpropamide—ABCB1—epithelium—skin cancer	0.000335	0.013	CbGeAlD
Chlorpropamide—ABCB1—mammalian vulva—skin cancer	0.00029	0.0113	CbGeAlD
Chlorpropamide—ABCB1—lymphoid tissue—skin cancer	0.000258	0.01	CbGeAlD
Chlorpropamide—ABCB1—female reproductive system—skin cancer	0.000249	0.00967	CbGeAlD
Chlorpropamide—PTGS1—lymph node—skin cancer	0.000246	0.00957	CbGeAlD
Chlorpropamide—ABCB1—head—skin cancer	0.000208	0.00808	CbGeAlD
Chlorpropamide—ABCB1—lymph node—skin cancer	0.000145	0.00566	CbGeAlD
